Carpal Tunnel Syndrome (cts) Clinical Trials
2 recruiting trials for Carpal Tunnel Syndrome (cts). Eligibility criteria explained in plain English.
TrialFinderData lists 2 Carpal Tunnel Syndrome (cts) clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Extremity Medical (1), Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is KinematX total wrist arthroplasty system (device, 1 trial), followed by Nerve conduction studies, Median nerve ultrasonography.
Track Carpal Tunnel Syndrome (cts) trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
The KinematX Midcarpal Total Wrist Arthroplasty Registry
The goal of this observational study is to learn about functional and patient reported outcomes in patient undergoing total wrist replacement with the KinematX total wrist...
Investigation of the Relationship Between Ultrasonographic Parameters and Tactile Sensation in Carpal Tunnel Syndrome
The aim of this study was to investigate the relationship between different ultrasonographic indices used in patients with carpal tunnel syndrome and the level of tactile...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Carpal Tunnel Syndrome (cts), with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Carpal Tunnel Syndrome (cts), review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Carpal Tunnel Syndrome (cts), representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.